Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Ciprofloxacin/dexamethasone

X
Drug Profile

Ciprofloxacin/dexamethasone

Alternative Names: 0.3% Ciprofloxacin/0.1% dexamethasone; CiloDex; CiloDex otic solution - Alcon; CiproDex Ophthalmic; CiproDex Otic; CiproDex Sterile Otic Suspension; Ciprofloxacin/dexamethasone otic suspension; Dexamethasone/ciprofloxacin

Latest Information Update: 15 Apr 2019

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Bayer
  • Developer Alcon; Bayer
  • Class Anti-inflammatories; Fluorinated steroids; Fluoroquinolones; Glucocorticoids
  • Mechanism of Action DNA gyrase inhibitors; DNA topoisomerase inhibitors; Glucocorticoid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Otitis externa; Otitis media
  • Discontinued Eye disorders

Most Recent Events

  • 09 Apr 2019 Novartis completed the spin-off of Alcon eye care devices business
  • 08 Apr 2011 Novartis completes acquisition of Alcon
  • 01 Mar 2011 Bayer Schering Pharma is now called Bayer HealthCare Pharmaceuticals

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top